Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Scope: Morin, a flavonoid occurring in many dietary plants, can reduce the number of synovial blood vessels and ameliorate collagen-induced arthritis (CIA) in rats. Herein, its underlying mechanisms in view of the peroxisome proliferator activated receptor-γ (PPARγ) pathway are addressed.
Methods And Results: In vitro, wound-healing and transwell assays are conducted to explore the effect of morin on HUVECs migration. Morin inhibits HUVECs migration and tube formation induced by VEGF, which is reversed by PPARγ antagonist GW9662 or siPPARγ. Molecular docking and competitive binding assays show that morin could bind to PPARγ. Morin increases the expression of PDK4 and CD36 in a PPARγ-dependent manner and increases the luciferase activity in cells transfected with PPARγ plasmid, which indicates that morin could activate PPARγ after binding. In addition, morin increases the expression of PTEN, a target gene of PPARγ that suppresses angiogenesis and inhibits PI3K/Akt signaling. The effects of morin on the PTEN-PI3K/Akt pathway are diminished by GW9662 and siPPARγ. In vivo studies show that morin ameliorates rat CIA, reduces synovial angiogenesis, and upregulates the expression of PTEN in the synovium, which is almost completely abolished by GW9662.
Conclusions: Morin is a potential agonist of PPARγ, which attenuates synovial angiogenesis and arthritis via the PPARγ-PTEN-PI3K/Akt pathway.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mnfr.201800202 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cross-platform transcriptomic data integration identifies an overactive neuro-immune signature in human osteoarthritis synovium.
Osteoarthritis Cartilage
August 2025
Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA; Institute for Biomechanics, Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland; Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA; Departmen
Objective: Chronic synovitis is associated with osteoarthritis (OA) pain, but the molecular underpinnings remain unclear. Our objective was to characterize the transcriptional phenotype of OA synovium with a focus on signaling relevant to pain.
Design: Eight publicly-available microarray and RNA-sequencing GEO datasets from human non-OA and OA subjects underwent quality control and re-analysis for differentially-expressed genes (DEGs).
Hedgehog signaling pathway: A research review on a new therapeutic target for rheumatoid arthritis.
Autoimmun Rev
August 2025
Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, China; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, China. Electronic address:
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive joint destruction, with existing therapies limited by adverse effects and incomplete efficacy. The Hedgehog signaling pathway, abnormally activated in RA, plays a pivotal pathogenic role by promoting synovial fibroblast proliferation/invasion, amplifying inflammatory responses, inducing chondrocyte matrix degradation, and enhancing angiogenesis. This review summarizes therapeutic strategies targeting this pathway, including small-molecule inhibitors (Smo/Gli antagonists), gene therapy (CRISPR-Cas, SMO-siRNA), and emerging approaches (mesenchymal stem cells, natural products).
View Article and Find Full Text PDFPlatelet-rich Plasma: A Tour d'horizon for its Application in Rheumatoid Arthritis.
Curr Drug Res Rev
June 2025
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Rheumatoid Arthritis (RA) is one of the most common inflammatory diseases, affecting millions of people worldwide, out of which 40% show poor clinical response while 5- 20% do not respond to current medications, including biologic and targeted therapies. Platelet- Rich Plasma (PRP), an autologous blood-derived product enriched with growth factors, has emerged as a new orthobiologic for the treatment of such non-responsive patients. The growth factors present in PRP influence various fundamental processes, including inflammation, angiogenesis, cell migration, and metabolism in RA.
View Article and Find Full Text PDFThe renin-angiotensin system (RAS) and arthritic diseases: therapeutic potential for RAS inhibitors.
Inflammopharmacology
August 2025
Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.
The renin-angiotensin system (RAS) is a pivotal hormonal regulator of cardiovascular and renal homeostasis, recently implicated in the etiology and progression of inflammatory arthritis, including rheumatoid arthritis (RA) and osteoarthritis (OA). This review explores the dual nature of RAS, highlighting its classical axis (ACE/Ang II/AT1R), which promotes inflammation and tissue damage, and its counter-regulatory axis (ACE2/Ang-(1-7)/MasR), which exhibits anti-inflammatory and protective effects. Elevated levels of RAS components in synovial fluid of arthritis patients emphasize its role in local joint pathology.
View Article and Find Full Text PDFFuhu Lijie Tang treats rheumatoid arthritis through multitarget therapy from autoantigen formation to bone destruction.
Phytomedicine
September 2025
State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China. El
Background: Rheumatoid arthritis (RA) is an incurable, disabling autoimmune disease, and combination therapy with disease-modifying antirheumatic drugs targeting different pathological mechanisms is a therapeutic strategy to improve treatment outcomes. Traditional Chinese medicine (TCM) offers the advantage of multi-component, multi-target therapy for RA; however, its ability to simultaneously target multiple key pathological mechanisms of RA remains to be further investigated. Fuhu Lijie Tang (FHLJT) is a novel TCM formulation with potential therapeutic effects on RA, and its anti-arthritic mechanisms require systematic study.
View Article and Find Full Text PDF